BACKGROUND: Observational studies of drug treatments complement pre-marketing drug trials and provide real-world outcomes of effectiveness and safety. Large UK primary care databases offer cost-effective access to clinical information for long-term studies requiring great statistical power and deliver findings representative of the general population. However, such data are not collected primarily for research, so all share weaknesses that must be offset by sophisticated use of statistical methodologies. This paper clarifies the current strengths and limitations of these data sources and discusses their potential. In the context of routinely collected primary care data sources, studies focusing on drug safety are used to show appropriate ap...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Background: High-risk primary care prescribing is common and is known to vary considerably between p...
BACKGROUND: Observational studies of drug treatments complement pre-marketing drug trials and provid...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Background: High-risk primary care prescribing is common and is known to vary considerably between p...
BACKGROUND: Observational studies of drug treatments complement pre-marketing drug trials and provid...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
The use of primary care databases has been integral in pharmacoepidemiological studies and pharmacov...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
This study measured the exposure to different categories of medicinal products discussed by the EU P...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Clinical studies that use observational databases to evaluate the effects of medical products have b...
Background: High-risk primary care prescribing is common and is known to vary considerably between p...